Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?

Clin Chem. 2016 Feb;62(2):307-9. doi: 10.1373/clinchem.2015.246538. Epub 2015 Dec 31.

Authors

Ana Babic¹, Brian M Wolpin²

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA.
² Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA. bwolpin@partners.org.

PMID: 26721295
DOI: 10.1373/clinchem.2015.246538

No abstract available

MeSH terms

Adenocarcinoma / diagnosis*
Adenocarcinoma / pathology
Biomarkers, Tumor / analysis*
Carcinoma, Pancreatic Ductal / diagnosis*
Carcinoma, Pancreatic Ductal / pathology
Case-Control Studies
Early Detection of Cancer / methods*
Exosomes* / pathology
Glypicans / analysis
Glypicans / metabolism
Humans
Pancreatic Neoplasms / diagnosis*
Pancreatic Neoplasms / pathology

Substances

Biomarkers, Tumor
Glypicans